Associations of hippocampal volumes, brain hypometabolism, and plasma NfL with amyloid, tau, and cognitive decline

Documenti analoghi

• Plasma P‐tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline
  di: Feng‐Feng Pan, et al.
  Pubblicazione: (2025)
• Combined use of plasma p‐tau217, NfL, and GFAP predicts domain‐specific cognitive decline in cognitively unimpaired and MCI individuals
  di: Chao‐Yi Wu, et al.
  Pubblicazione: (2025)
• Brain age correlates with plasma NfL in amyloid positive individuals
  di: Saurabh Sihag, et al.
  Pubblicazione: (2024)
• Baseline plasma NfL, p‐tau217 and tau‐PET SUVr predict cognitive decline in non‐demented persons from a memory clinic
  di: Augusto J. Mendes, et al.
  Pubblicazione: (2024)
• Imaging of amyloid, tau and synaptic dysfunction in the brains of type 2 diabetic rats ‐ a multitracer PET study
  di: Yanyan Kong, et al.
  Pubblicazione: (2024)